Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2008
11/26/2008CN101311167A 1-phenyl glyoxaline alkane -2,4-dione derivates and uses thereof
11/26/2008CN101310760A Traditional Chinese medicine for preventing and treating metabolism syndrome
11/26/2008CN101310751A Traditional Chinese medicine composition for replenishing qi and blood, preparation method and quality control method thereof
11/26/2008CN101310723A Use of compounds that are effective as selective opiate receptor modulators
11/26/2008CN101310718A Composition containing catechin for reducing weight and blood fat and use thereof
11/26/2008CN101310716A Therapeutic agent
11/26/2008CN101310621A Weight-reducing food and production method thereof
11/26/2008CN100436588C Blood sugar reducing method of orally taking human insulin-like growth factor-I produced in silkworm bioreactor
11/26/2008CN100436578C Modulation of the transcription of pro-inflammatory gene products
11/26/2008CN100436462C Reaction method of biological alkali, reaction product and use thereof
11/26/2008CN100436452C Pyrazole compounds useful as protein kinase inhibitors
11/26/2008CN100436439C Dimeric isoflavones
11/26/2008CN100436430C Alkanoyl substituted tyrosine derivatives as hPPAR alpha and hPPAR gamma agonist
11/26/2008CN100436427C Aminobenzamide derivatives as glycogen synthase kinase 3 beta inhibitors
11/26/2008CN100436420C 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
11/26/2008CN100435810C Dogwood fruit extract and its preparation process
11/26/2008CN100435800C Composition for losing weight
11/26/2008CN100435793C Medicament, containing effector of glutathione metabolism together with alpha-lipoic acid for use in kidney replacement therapy
11/26/2008CN100435790C EGCG-zinc complex solid dispersion, its preparation method and application
11/26/2008CN100435788C Inhibitor for perioperative blood sugar elevation
11/26/2008CN100435787C Preventive or remedy for intrauterine late embryonic development or pregnancy toxemia
11/26/2008CN100435785C Methods and compounds for inhibiting amyloid deposits
11/26/2008CN100435665C Starch sub types and lipid metabolism
11/26/2008CN100435664C Compound nutrients of hydrolyzed yeast , pollen, complete animal and plant essential fatty acid and its preparation method
11/25/2008US7456297 crystalline polymorphic dosage forms of anticholesterol agents; statins; small particle size distribution
11/25/2008US7456253 Growth hormone releasing peptides
11/25/2008US7456217 Administering N-(2,6-Dichlorobenzoyl)-4-(2,6-dimethoxy-4-methoxymethylphenyl)-L-phenylalanine ethyl ester for therapy of multiple sclerosis
11/25/2008US7456205 Non-insulin dependent diabetes; 7-[2-(5-methyl-2-phenyl-4-oxazole)ethoxyl]-2-oxo-2H-1-benzopyran-3-carboxylic acid methyl ester; insulin-sensitizing activities
11/25/2008US7456204 Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/25/2008US7456190 autoimmune disease; antiinflammatory agents; bone disorders; central nervous system disorders; cardiovascular disorders; Alzheimer's disease; antihistamines; antiallergens
11/25/2008US7456183 Melanocortin-4 receptor agonists; obesity, type II diabetes; such as N-(2-(2-(2,4-dichlorophenyl)ethyl)-1-oxo-2,3-dihydro-1H-isoindol-5-yl) -3-methyl-N'-(2,6,6-trimethylbicyclo(3.1.1)hept-3yl)piperazine-1-carboximidamide
11/25/2008US7456180 Piperazine derivatives and their use as therapeutic agents
11/25/2008US7456168 2-(pyridin-2-ylamino)-pyrido[2,3, d]pyrimidin-7-ones
11/25/2008US7456158 4-dedimethylaminotetracycline derivatives
11/25/2008US7456156 Aryl boronic acids for treating obesity
11/25/2008US7456150 Pulmonary delivery of active fragments of parathyroid hormone
11/25/2008US7455984 Immunoreactive and immunotherapeutic molecules
11/25/2008US7455835 Administering soluble cytotoxic t-lymphocyte associated antigen (ctla4) molecule that binds a cell surface B7 molecule
11/25/2008CA2367666C Method of treating eating disorders
11/25/2008CA2318579C Nitrogen-containing heterocyclic compounds and medicaments containing the compounds
11/25/2008CA2204406C Lipid metabolism improving agent
11/20/2008WO2008141021A1 Deuterated derivatives of tetrahydrotriazolopyrazine compounds and their use as dpp-iv inhibitors
11/20/2008WO2008140064A1 Nutrient composition for prevention and amelioration of lifestyle-related disease
11/20/2008WO2008139987A1 G-protein-conjugated receptor agonist
11/20/2008WO2008139965A1 Novel vitamin b6 derivative
11/20/2008WO2008139879A1 G protein-coupled receptor inhibitor and pharmaceutical product
11/20/2008WO2008139845A1 Novel amide derivative
11/20/2008WO2008139576A1 Method for producing lactam compound and production intermediate thereof
11/20/2008WO2008139575A1 Preparation for oral administration
11/20/2008WO2008139574A1 Crystalline form of lactam compound and process for producing the same
11/20/2008WO2008138995A1 New pharmaceutical compositions comprising a thyroid hormon and their therapeutic use
11/20/2008WO2008138993A1 New pharmaceutical compositions comprising diiodothyronine and their therapeutic use
11/20/2008WO2008138920A1 Dihydroquinone and dihydronaphthridine inhibitors of jnk
11/20/2008WO2008138191A1 A composition for treatment of diabetes mellitus and a preparation and an use thereof
11/20/2008WO2008138184A1 Derivatives of pyrroloazacycles, the method of making them and the use thereof as inhibitors of protein kinases
11/20/2008WO2008138123A1 Screening assay to identify correctors of protein trafficking defects
11/20/2008WO2008116195A3 Compositions comprising an sglt2 ingibitor for treating obesity
11/20/2008WO2008109697A3 Ppar active compounds
11/20/2008WO2008096203A3 Food extracts containing n-methylnicotinamide for treatment of lipoprotein abnormalities and skin diseases and disorders
11/20/2008WO2008092591A3 Use of guanidinoacetic acid (salts) combined with betaine and/or choline for producing a health-promoting agent
11/20/2008WO2008065408A3 Modulation of prostaglandin/cyclooxygenase metabolic pathways
11/20/2008US20080287674 Inhibitors of Factor XA and Other Serine Proteases Involved in the Coagulation Cascade
11/20/2008US20080287544 Method for Screening Substance by Measuring PPAR DELTA Activating Effect and Agent
11/20/2008US20080287529 Crystal structures of sglt2 inhibitors and processes for preparing same
11/20/2008US20080287521 Crystalline Forms Of [R-(R*,R*)-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methyl- Ethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid Calcium Salt (2:1)
11/20/2008US20080287517 Pyrazole Derivatives as Cb1 Modulators
11/20/2008US20080287505 Substituted 2-methyl-2-phenoxy-n-propyl-propionamides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity
11/20/2008US20080287504 Such as N-(4-Fluoro-benzyl)-4-(3-phenyl-indole-1-sulfonyl)-benzamide; Cannabinoid-1 (CB1) receptor; dietetics
11/20/2008US20080287503 Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases
11/20/2008US20080287501 Therapeutic uses of an insulin secretion enhancer
11/20/2008US20080287495 Novel benzo[d][1,3]-dioxol derivatives
11/20/2008US20080287477 Novel Compounds as Modulators of Ppar
11/20/2008US20080287476 Administration of dipeptidyl peptidase inhibitors
11/20/2008US20080287466 4-amino-2,3-disubstituted thieno [2,3,d]pyrimidines and pharmaceutical compositions thereof
11/20/2008US20080287450 Novel Substituted Tetracyclic Tetahydrofuran, Pyrrolidine And Tetrahydrothiophene Derivatives
11/20/2008US20080287448 Diacyl indazole derivatives as lipase and phospholipase inhibitors
11/20/2008US20080287444 Pyrazole compounds useful as protein kinase inhibitors
11/20/2008US20080287423 Antidiabetic agents; neurodegenerative disorders; mixture with immunosuppresants
11/20/2008US20080287409 Phenyl and pyridinyl-1,2,4-oxadiazolone derivatives, processes for their preparation and their use as pharmaceutical compositions
11/20/2008US20080287407 Nitric Oxide Releasing Pyruvate Compounds, Compositions and Methods of Use
11/20/2008US20080287403 Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events
11/20/2008US20080287390 Pyrazolidinol compounds
11/20/2008US20080287386 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases
11/20/2008US20080287344 Use of Amino Acids for Making Medicines for Treating Insulin Resistance
11/20/2008US20080287343 Method for reducing cardiovascular morbidity and mortality in prediabetic patients and patients with type 2 diabetes
11/20/2008US20080286392 Body Fat-Reducing Agent
11/20/2008US20080286354 administering a bile acid e.g ursodiol, ursodiol bicarbonate and ursodiol sulfate, a fibrate e.g. bezafibrate, fenofibrate, gemfibrozil, ciprofibrate and derivatives of 2-phenoxy-2-methylpropanoic acid, and a statin e.g. simvastatin, fluvastatin, pravastatin, atorvastatin to treat chronic hepatitis
11/20/2008US20080286344 Film to encapsulate pharmaceutical, agrochemical, detergent active ingredients; fill material less compacted than in a tablet but more than in a capsule; controlled release; fewer, lower quantities of excipients
11/20/2008US20080286343 Solid form
11/20/2008US20080286301 Treatment of diabetes
11/20/2008US20080286288 Vascular endothelial growth factor 2
11/20/2008US20080286265 Substituted phenoxy n-alkylated thiazolidinediones as estrogen related receptor-alpha modulators
11/20/2008US20080286254 Composition comprising licorice polyphenol
11/20/2008CA2687715A1 Screening assay to identify correctors of protein trafficking defects
11/20/2008CA2687385A1 New pharmaceutical compositions comprising a thyroid hormon and their therapeutic use
11/20/2008CA2687380A1 New pharmaceutical compositions comprising diiodothyronine and their therapeutic use
11/20/2008CA2686385A1 Dihydroquinone and dihydronaphthridine inhibitors of jnk
11/19/2008EP1992641A2 GLP-1 analogues
11/19/2008EP1992636A2 Process for correction of a disulfide misfold in Fc molecules
11/19/2008EP1992624A1 Heteroarylamide pyrimidone compounds
1 ... 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 ... 1298